Effects of HMGCR deficiency on skeletal muscle development

Mekala Gunasekaran,Hannah R. Littel,Natalya M. Wells,Johnnie Turner,Gloriana Campos,Sree Venigalla,Elicia A. Estrella,Partha S. Ghosh,Audrey L. Daugherty,Seth A. Stafki,Louis M. Kunkel,A. Reghan Foley,Sandra Donkervoort,Carsten G. Bönnemann,Laura Toledo-Bravo de Laguna,Andres Nascimento,Daniel Natera-de Benito,Isabelle Draper,Christine C. Bruels,Christina A. Pacak,Peter B. Kang
DOI: https://doi.org/10.1101/2024.05.06.591934
2024-05-08
Abstract:Pathogenic variants in were recently linked to a limb-girdle muscular dystrophy (LGMD) phenotype. The protein product HMG CoA reductase (HMGCR) catalyzes a key component of the cholesterol synthesis pathway. The two other muscle diseases associated with HMGCR, statin-associated myopathy (SAM) and autoimmune anti-HMGCR myopathy, are not inherited in a Mendelian pattern. The mechanism linking pathogenic variants in with skeletal muscle dysfunction is unclear. We knocked down in mouse skeletal myoblasts, knocked down in Drosophila, and expressed three pathogenic variants (c.1327C>T, p.Arg443Trp; c.1522_1524delTCT, p.Ser508del; and c.1621G>A, p.Ala541Thr) in knockdown mouse myoblasts. deficiency was associated with decreased proliferation, increased apoptosis, and impaired myotube fusion. Transcriptome sequencing of knockdown versus control myoblasts revealed differential expression involving mitochondrial function, with corresponding differences in cellular oxygen consumption rates. Both ubiquitous and muscle-specific knockdown of in Drosophila led to lethality. Overexpression of reference cDNA rescued myotube fusion in knockdown cells, whereas overexpression of the pathogenic variants of cDNA did not. These results suggest that the three HMGCR-related muscle diseases share disease mechanisms related to skeletal muscle development.
Developmental Biology
What problem does this paper attempt to address?